ANG LIFESCIENCES INDIA
|
|
BOM : 540694     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : NA |
May 29,2023 |
Price(EOD): βΉ 75.12
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: βΉ 98.41 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
ANG LIFESCIENCES INDIA | -3.1% | -10.4% | -57.2% |
SUN PHARMACEUTICAL INDUSTRIES | 4% | -1.1% | 6.6% |
DIVIS LABORATORIES | 2.8% | 7.5% | -4.1% |
CIPLA | 2.7% | 4.6% | -2% |
DR REDDYS LABORATORIES | 2.2% | -7.4% | 4.1% |
TORRENT PHARMACEUTICALS | 0.8% | 4.6% | 31.3% |
ABBOTT INDIA | 1.8% | -1.2% | 20.3% |
ZYDUS LIFESCIENCES | 1% | -0.6% | 37.9% |
ALKEM LABORATORIES | 2.9% | -2.4% | 14.1% |
FUNDAMENTAL ANALYSIS OF ANG LIFESCIENCES INDIA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF ANG LIFESCIENCES INDIA
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
10.22
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 9.60 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] 1.17
P/B Calculated based on Book Value of Rs 83.77 Cr
[Latest Year - Mar2022 - Consolidated Results ] 0.36
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 275.83 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-38% 283% 29% |
SHARE PRICE MOMENTUM OF ANG LIFESCIENCES INDIA
ANG LIFESCIENCES INDIA vs SENSEX
DEBT OF ANG LIFESCIENCES INDIA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.73 1.03 0.6 0.79 |
0.92 - - 0.31 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF ANG LIFESCIENCES INDIA
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF ANG LIFESCIENCES INDIA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-21.55% -71.44% -159.29% -167.58% |
-5.41% -48.23% -233.93% -239.4% |
QtrlyTrend |
-8 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
ANG LIFESCIENCES INDIA related INDICES
You may also like the below Video Courses
FAQ about ANG LIFESCIENCES INDIA
Is ANG LIFESCIENCES INDIA good for long term investment?
As on May 29,2023, the Fundamentals of ANG LIFESCIENCES INDIA look Poor and hence it may not be good for long term investment ! See Financial Performance of ANG LIFESCIENCES INDIA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is ANG LIFESCIENCES INDIA UnderValued or OverValued?
As on May 29,2023, ANG LIFESCIENCES INDIA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of ANG LIFESCIENCES INDIA ?
As on May 29,2023, the Intrinsic Value of ANG LIFESCIENCES INDIA is Rs. 58.41 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 121.93
Fair Value [Median EV / Sales Model] : Rs. 19.63
Fair Value [Median Price / Sales Model] : Rs. 58.41
Estimated Median Fair Value of ANG LIFESCIENCES INDIA : Rs. 58.41
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is ANG LIFESCIENCES INDIA trading at a Premium or Discount?
As on May 29,2023, ANG LIFESCIENCES INDIA is trading at a Premium of 29% based on the estimates of Median Intrinsic Value!